Wells Fargo & Company »

Seelos Therapeutics Inc Class Equity shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Seelos Therapeutics Inc Class Equity shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Seelos Therapeutics Inc Class Equity

Tip: Access up to 7 years of quarterly data

All positions including Seelos Therapeutics Inc Class Equity held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seelos Therapeutics Inc Class Equity by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2024-06-30 $24 41 0.59

More positions owned by Wells Fargo & Company

Microsoft Corporation Call Option (MSFT)
Apple Put Option (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p Ttl Stk (ITOT)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Index Fds Mid Cap Etf (VO)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)
UnitedHealth Call Option (UNH)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Wells Fargo & Company

Top funds holding Seelos Therapeutics Inc Class Equity

AdvisorShares Investments
Morgan Stanley
Geode Capital Management
BlackRock
Tower Research Capital
Jpmorgan Chase & Co
Bank of America Corporation
Group One Trading
Vermillion & White Wealth Management Group
Crewe Advisors
Wells Fargo & Company
Newbridge Financial Services Group
Westside Investment Management
National Bank Of Canada /fi/
Pnc Financial Services

View all funds holding Seelos Therapeutics Inc Class Equity